Search
Racecadotril
go.drugbank.com/drugs/DB11696InvestigationalRacecadotril has been investigated for the basic science and treatment of Diarrhea, Acute Diarrhea, and Acute Gastroenteritis.
Categories: N-substituted GlycinesProducts: Hidrasec Infants 10mg Granules for Oral Suspension, Hidrasec Children 30mg Granules for Oral SuspensionPF-03654746
go.drugbank.com/drugs/DB12201InvestigationalPF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome, and Excessive Daytime Sleepiness.
Pexacerfont
go.drugbank.com/drugs/DB12572InvestigationalPexacerfont has been investigated for the treatment of Alcoholism, Anxiety Disorder, Alcohol Dependence, and Alcohol-Related Disorders.
KB109
go.drugbank.com/drugs/DB16531ExperimentalKB109 is a prebiotic to feed healthy bacteria for them to to outcompete multi-drug resistance organisms.
RTL-1000
go.drugbank.com/drugs/DB17946InvestigationalRTL-1000 is a recombinant T-Cell receptor ligand being investigated for the treatment of multiple sclerosis.
Canvuparatide
go.drugbank.com/drugs/DB18658InvestigationalCanvuparatide is a long-acting parathyroid hormone peptide prodrug under investigation for the treatment of hyperparathyroidism.[L48365]
Tagorizine
go.drugbank.com/drugs/DB20098ExperimentalTagorizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Tagorizine is a antihistaminic/cerebral (or peripheral) vasodilator. … Tagorizine has a monoisotopic molecular weight of 468.29 Da.
Belarizine
go.drugbank.com/drugs/DB20540ExperimentalBelarizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Belarizine is a antihistaminic/cerebral (or peripheral) vasodilator. … Belarizine has a monoisotopic molecular weight of 358.2 Da.
Trelnarizine
go.drugbank.com/drugs/DB21183ExperimentalTrelnarizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Trelnarizine is a antihistaminic/cerebral (or peripheral) vasodilator. … Trelnarizine has a monoisotopic molecular weight of 464.23 Da.
Icrucumab
go.drugbank.com/drugs/DB14824InvestigationalIcrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).